PR Newswire - End of Day
- 25
PR Newswire - End of Day
PR Newswire
London, August 13
PR Newswire This is the END of day message for the PR Newswire Disclose service Disclaimer The content and accuracy of all information published on the Disclose service is the responsibility of the originating company or organisation and not PR Newswire or distributing companies. These companies include (but are not limited to) Thomson Reuters, Bloomberg, and FE Investegate. However, PR Newswire shall use its reasonable efforts to correct any error or omission brought to its attention. Neither PR Newswire nor its distributing companies who place the information onto their services accept any responsibility for any use made of the information provided on the Disclose service and they will not be liable for any loss suffered thereby. However nothing shall limit any party's liability for fraud, death or personal injury caused by its negligence. All information contained in the Disclose service should be independently checked prior to any use or publication. END
PR Newswire
PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.
Lastest news
- Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
- Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
- The Gross Law Firm Reminds agilon health, inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 - AGL
- The Gross Law Firm Reminds Innoviz Technologies Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 14, 2024 - INVZ
- Baozun Releases 2023 Chairman Letter
- Uxin to Report Third Quarter Fiscal Year 2024 Financial Results on April 25, 2024